In a validation cohort, the levels of eight peptides derived from NFL, MAP1B, MYL1, APOC1, CADM3, SCG1, and PENK proteins changed in ALS compared to controls. The gene discussed is CHGB; the disease is amyotrophic lateral sclerosis.